Table of contents

Liver disease

• Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report (1 November, 2000)

  H Zylberberg, Y Benhamou, J L Lagneaux, A Landau, M-L Chaix, H Fontaine, M Bochet, T Poynard, C Katlama, G Pialoux, C Bréchot, S Pol
• Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients (1 November, 2000)

  T Bizollon, S N Si Ahmed, S Guichard, P Chevallier, M Adham, C Ducerf, J Baulieux, C Trepo
• Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk

  (1 November, 2000)

  M-W Yu, C-I Pai, S-Y Yang, T-J Hsiao, H-C Chang, S-M Lin, Y-F Liaw, P-J Chen, C-J Chen
• Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease (1 November, 2000)

  P Ljubuncic, Z Tanne, A Bomzon
• Co-amoxiclav jaundice: clinical and histological features and HLA class II association (1 November, 2000)

  J O'Donohue, K A Oien, P Donaldson, J Underhill, M Clare, R N M MacSween, P R Mills